SYK Stryker Corp

  1. Stocks
  2. Healthcare
  3. NYSE: SYK

Price (delayed)

$223.12

Market cap

$84.41B

P/E Ratio

40.49

Dividend/share

$2.72

EPS

$5.51

Enterprise value

$96.75B

Stryker Corporation is an American multinational medical technologies corporation based in Kalamazoo, Michigan. Stryker's products include implants used in joint replacement and trauma surgeries; surgical equipment and surgical navigation systems; ...

Highlights
SYK's P/E is 14% below its last 4 quarters average of 47.2 and 5% below its 5-year quarterly average of 42.6
SYK's equity is up by 13% year-on-year and by 4.2% since the previous quarter
SYK's debt is down by 5% from the previous quarter but it is up by 5% YoY
SYK's quick ratio is down by 18% YoY and by 6% from the previous quarter
Sector: Healthcare
Industry: Medical Devices
Website: https://www.stryker.com/
Peers: MDT BSX EW BAX

Key stats

What are the main financial stats of SYK
Market
Shares outstanding
378.32M
Market cap
$84.41B
Enterprise value
$96.75B
Valuations
Price to earnings (P/E)
40.49
Price to book (P/B)
5.38
Price to sales (P/S)
4.79
EV/EBIT
41.03
EV/EBITDA
35.48
EV/Sales
5.49
Earnings
Revenue
$17.63B
EBIT
$2.36B
EBITDA
$2.73B
Free cash flow
$2.07B
Per share
EPS
$5.51
Free cash flow per share
$5.46
Book value per share
$41.45
Revenue per share
$46.6
TBVPS
$41.43
Balance sheet
Total assets
$36.03B
Total liabilities
$20.36B
Debt
$13.38B
Equity
$15.67B
Working capital
$4.42B
Liquidity
Debt to equity
0.85
Current ratio
2
Quick ratio
0.97
Net debt/EBITDA
4.52
Margins
EBITDA margin
15.5%
Gross margin
63.8%
Net margin
11.8%
Operating margin
14.8%
Efficiency
Return on assets
5.9%
Return on equity
13.9%
Return on invested capital
10.4%
Return on capital employed
7.5%
Return on sales
13.4%
Dividend
Dividend yield
1.22%
DPS
$2.72
Payout ratio
49.3%

SYK stock price

How has the Stryker stock price performed over time
Intraday
2.34%
1 week
3.4%
1 month
14%
1 year
-14.48%
YTD
-16.57%
QTD
12.16%

Financial performance

How have Stryker's revenue and profit performed over time
Revenue
$17.63B
Gross profit
$11.25B
Operating income
$2.61B
Net income
$2.08B
Gross margin
63.8%
Net margin
11.8%
Stryker's operating margin has decreased by 14% YoY
The company's revenue rose by 9% YoY
SYK's net margin is down by 8% YoY
Stryker's gross profit has increased by 8% YoY

Growth

What is Stryker's growth rate over time

Valuation

What is Stryker stock price valuation
P/E
40.49
P/B
5.38
P/S
4.79
EV/EBIT
41.03
EV/EBITDA
35.48
EV/Sales
5.49
SYK's P/E is 14% below its last 4 quarters average of 47.2 and 5% below its 5-year quarterly average of 42.6
Stryker's EPS has increased by 3% from the previous quarter
SYK's P/B is 15% below its last 4 quarters average of 6.3 and 13% below its 5-year quarterly average of 6.2
SYK's equity is up by 13% year-on-year and by 4.2% since the previous quarter
The stock's price to sales (P/S) is 13% less than its last 4 quarters average of 5.5 and 8% less than its 5-year quarterly average of 5.2
The company's revenue rose by 9% YoY

Efficiency

How efficient is Stryker business performance
Stryker's ROS has decreased by 12% YoY
The ROE fell by 11% YoY
Stryker's ROIC has decreased by 9% YoY
The ROA has contracted by 4.8% YoY

Dividends

What is SYK's dividend history
Dividend details
DPS
$2.72
Dividend yield
1.22%
Payout ratio
49.3%
Recent dividends

Financial health

How did Stryker financials performed over time
The total assets is 77% greater than the total liabilities
SYK's quick ratio is down by 18% YoY and by 6% from the previous quarter
The total assets has increased by 7% year-on-year
SYK's debt is 15% less than its equity
SYK's equity is up by 13% year-on-year and by 4.2% since the previous quarter
The debt to equity has contracted by 10% from the previous quarter and by 8% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.